HeartSciences Inc. (HSCS)
↓ Download CSV- Sector Finance & Real Estate
- Incorporated TX
- Fiscal year ends Apr 30
In fiscal 2026, HeartSciences Inc. reported revenue of $4.3K, down 0.7% from the prior year. The company ran a net loss, with a net margin of -211666.5% and a gross margin of 59.1%. It held $5.26M in total assets against $5.04M in total liabilities.
Key ratios (FY2026)
59.1%
Gross margin
-194787.4%
Operating margin
-211666.5%
Net margin
-4044.0%
Return on equity
-0.7%
Revenue growth (YoY)
| Metric (FY) | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $4.3K | $4.3K | $18.6K | $5.2K | $14.4K | — |
| Cost of Revenue | $1.8K | $1.9K | $6.1K | $2.8K | $7.9K | — |
| Gross Profit | $2.6K | $2.5K | $12.5K | $2.4K | $6.5K | — |
| Operating Income | -$8.41M | -$8.35M | -$6.31M | -$6.11M | -$4.71M | — |
| Net Income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -$4.83M | — |
| EPS (Diluted) | $-3.48 | $-9.34 | $-18.74 | $-80.00 | $-1.45 | — |
| Total Assets | $5.26M | $4.22M | $9.50M | $3.29M | $2.09M | — |
| Total Liabilities | $5.04M | $4.02M | $2.19M | $3.06M | $8.15M | — |
| Shareholders' Equity | $226.1K | $205.2K | $7.32M | $230.6K | -$6.06M | -$1.91M |
| Cash & Equivalents | $1.66M | $1.10M | $5.81M | $1.66M | $918.3K | — |
| Operating Cash Flow | -$7.43M | -$7.41M | -$6.07M | -$5.77M | -$3.64M | — |
| Capital Expenditures | $3.6K | $3.2K | $64.5K | $18.3K | $1.9K | — |
| Shares Outstanding | 3.19M | 1.12M | 676.6K | 101.3K | 3.32M | — |
| Dividends Per Share | $0.00 | $0.00 | — | — | — | — |